Core Viewpoint - The company announced that its wholly-owned subsidiary, Xinxiang Jingquan Biotechnology Co., Ltd., has obtained a drug production license from the Henan Provincial Drug Administration, which allows for the compliant production of Coenzyme Q10 raw materials, positively impacting the company's health business segment and long-term development [1] Group 1 - The license number issued is 豫20260007, and the production address is located at 266 Jingquan East Road, Xinxiang High-tech Zone, Henan Province [1] - The approval signifies that the company's related products for Coenzyme Q10 raw materials now meet the necessary compliance production qualifications [1] - This development is expected to enhance the company's strategic positioning in the health sector and support its long-term growth initiatives [1]
拓新药业：子公司取得辅酶Q10原料药生产许可证